English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Purpose . To assess whether the differences in vascular-metabolic relationships between lymphoma masses and colorectal liver metastases predicted from previous histopathological studies can be demonstrated by dynamic contrast-enhanced CT (DCE-CT) combined with fluorodeoxyglucose positron emission tomography (FDG-PET).  Methods . DCE-CT and FDG-PET studies were drawn from an imaging archive for patients with either lymphoma masses ( n  = 11) or hepatic metastases from colorectal cancer (CRM:  n  = 12). Tumour vascularity was assessed using DCE-CT measurements of perfusion. Tumour glucose metabolism was expressed as the mean FDG Standardised Uptake Value (SUV FDG ). The relationship between metabolism and vascularity in each group was assessed from SUV FDG  /perfusion ratios and Pearson correlation coefficients.  Results . An SUV FDG  threshold of 3.0 was used to designate lymphoma masses as active (AL,  n  = 6) or inactive lymphoma (IL,  n  = 5). Tumour perfusion was significantly higher in AL (0.65 mL/min/mL) than CRM (0.37 mL/min/mL:  P  = .031) despite similar SUV FDG  (5.05 and 5.33, resp.). AL demonstrated higher perfusion values than IL (0.24 mL/min/mL:  P  = .006). SUV FDG /perfusion was significantly higher in CRM (15.3 min) than IL (4.2 min,  P  < .01). There was no correlation between SUV FDG  and perfusion for any patient group.

Demonstrating Intertumoural Differences in Vascular-Metabolic Phenotype with Dynamic Contrast-Enhanced CT-PET